Clinical trial
Papua New Guinean Duffy Negativity And Vivax Malar
NCT00138489 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Terminated
Key facts
| NCT number | NCT00138489 |
|---|---|
| Title | Papua New Guinean Duffy Negativity And Vivax Malar |
| Official title | Protocol 3B Susceptibility to Plasmodium Vivax Infection and Malaria During Early Childhood |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Terminated |
| Study type | Observational |
| Conditions | Plasmodium Vivax Malaria |
| Enrollment | 266 |
| Start date | Feb 10, 2004 |
| First posted | Aug 30, 2005 |
| Last update posted | Feb 4, 2019 |
| Countries | Papua New Guinea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: